Highlights
- Epidemiological data from over 500,000 participants in the UK Biobank demonstrate that regular physical activity (PA) is independently associated with a lower risk of developing chronic pancreatitis (CP).
- Skeletal muscle-derived extracellular vesicles (EVs) serve as a systemic delivery vehicle for the protein PRDX6, which accumulates in the inflamed pancreas to inhibit ferroptosis and innate immune activation.
- The protective mechanism involves the suppression of the cGAS-STING pathway, specifically through PRDX6 binding to the zinc-thumb motif of cGAS, thereby dampening mitochondrial DNA-driven inflammation.
- Resistance exercise appears to offer superior protection compared to aerobic exercise in reducing pancreatic injury and fibrosis in experimental models.
Background
Chronic pancreatitis (CP) is a debilitating, progressive fibroinflammatory disorder characterized by irreversible morphological changes, persistent immune activation, and significant exocrine and endocrine insufficiency. Despite its heavy clinical burden, therapeutic options remain largely symptomatic, focusing on pain management and enzyme replacement rather than altering the disease’s natural history. Traditionally, clinicians have been cautious regarding physical activity (PA) in CP patients, often presuming it to be neutral or potentially harmful due to the systemic stress of exercise.
However, a paradigm shift is occurring. Emerging evidence suggests that skeletal muscle acts as an endocrine organ, releasing ‘myokines’ and extracellular vesicles (EVs) that modulate systemic inflammation. The recent landmark study by Tong et al. (Gut, 2026) provides a robust clinical and mechanistic foundation for the protective role of exercise in CP, shifting the focus from sedentary management to active therapeutic mobilization.
Key Content
1. Epidemiological Evidence: The UK Biobank and Clinical Validation
The association between PA and CP risk was rigorously evaluated using the UK Biobank cohort, encompassing over 500,000 participants. The results revealed that regular PA is independently associated with a significantly lower risk of CP. This protective effect remained consistent across different levels of alcohol consumption—one of the primary risk factors for CP—and across various disease subtypes. Validation in an independent clinical cohort further confirmed that CP patients who were physically active exhibited milder clinical manifestations and slower disease progression compared to their sedentary counterparts.
2. Experimental Insights: Resistance vs. Aerobic Exercise
In murine models of experimental CP, exercise interventions—both as a preconditioning measure and after the initiation of the disease—attenuated pancreatic injury and fibrosis. Notably, the research highlighted that while all exercise was beneficial, resistance training provided more pronounced protection against pancreatic damage. These interventions resulted in a reduction in histopathological injury scores and a significant decrease in the markers of ferroptosis, a form of iron-dependent programmed cell death that drives acinar cell loss and inflammation in the pancreas.
3. The Muscle-Pancreas Axis: Extracellular Vesicles as Messengers
Mechanistically, the study identified skeletal muscle-derived extracellular vesicles (EVs) as the primary mediators of this systemic protection. During physical activity, skeletal muscle releases an increased quantity of EVs into the circulation. These exercise-induced EVs were shown to accumulate preferentially within the inflamed pancreatic tissue.
When EV release was pharmacologically or genetically inhibited in mice, the protective benefits of exercise on the pancreas were partially abolished, confirming that these vesicles are essential for the observed therapeutic effect. This suggests a novel form of inter-organ communication where the musculoskeletal system directly influences pancreatic homeostasis through vesicular transport.
4. Molecular Target: The PRDX6-STING Pathway
Proteomic profiling of these muscle-derived EVs identified Peroxiredoxin 6 (PRDX6) as a critical vesicular cargo. PRDX6 is a multi-functional enzyme known for its antioxidant and phospholipase activities. In the context of CP, vesicular PRDX6 performs two vital functions:
- Inhibition of Ferroptosis: PRDX6 protects acinar cells from lipid peroxidation and iron-mediated death.
- Suppression of STING Activation: PRDX6 binds to the zinc-thumb motif of cyclic GMP-AMP synthase (cGAS). This binding prevents cGAS from sensing mitochondrial DNA (mtDNA) released during cell injury, thereby inhibiting the activation of the Stimulator of Interferon Genes (STING) pathway.
By dampening myeloid STING signaling, exercise-induced EVs promote an inflammation-resolving state within the intrapancreatic immune environment, effectively ‘resetting’ the immune programme from a pro-fibrotic to a reparative phenotype.
5. Advancements in Diagnosis and Severity Prediction
Parallel to these mechanistic insights, the field of pancreatology is leveraging EV biology for improved diagnostics. Recent studies (Gut, 2026; PMID: 41991276) have utilized circulating EV long RNA (ExLR) profiling combined with machine learning to create highly accurate diagnostic signatures (ExLRCPdscore). These tools can detect early-stage CP even in the absence of imaging findings or alarm symptoms. Furthermore, machine learning models are now being used to predict mortality in acute pancreatitis (AP) with high precision (C-index of 0.84), identifying age, blood urea nitrogen, and bilirubin as key predictors (PMID: 41397146). These diagnostic advances complement the therapeutic findings by providing a way to monitor the biological response to exercise interventions at the molecular level.
Expert Commentary
The discovery of the muscle-pancreas axis represents a significant leap forward in evidence-based lifestyle medicine for GI disorders. For years, the role of exercise in CP was undervalued. The demonstration that PA can reprogram the pancreatic immune microenvironment provides a biological rationale for incorporating ‘exercise prescriptions’ into standard CP care.
However, several considerations remain. While resistance exercise showed superior benefits in animal models, translating this to human CP patients requires care. Many CP patients suffer from sarcopenia and malnutrition; therefore, any exercise regimen must be balanced with nutritional support. Furthermore, the role of autoimmune components cannot be ignored. Identification of novel antibodies in autoimmune pancreatitis (AIP), such as those against PBP (PMID: 19940298), suggests that the immune landscape of the pancreas is highly heterogeneous. Whether PA benefits all forms of CP—including AIP—remains an area for future investigation.
From a translational perspective, the identification of PRDX6 and the STING pathway as key players opens the door for ‘exercise mimetics’—pharmacological agents that could activate these pathways in patients who are physically unable to exercise. Additionally, using ExLR profiling to monitor acinar-to-ductal metaplasia (ADM) scores could serve as a non-invasive way to track treatment efficacy.
Conclusion
Physical activity is no longer just a general health recommendation for patients with pancreatic disorders; it is a targeted intervention that reshapes the intrapancreatic immune landscape. By mobilizing muscle-derived EVs and PRDX6 to suppress STING-driven inflammation and ferroptosis, exercise actively restrains the progression of chronic pancreatitis. Future research should focus on optimizing exercise protocols for different CP phenotypes and exploring the potential of EV-based therapies to mimic these profound biological benefits.
References
- Tong J, et al. Physical activity reshapes intrapancreatic immune and inflammatory programmes to restrain chronic pancreatitis. Gut. 2026; PMID: 42209195.
- Wu JW, et al. Circulating extracellular vesicle long RNA profiling combined with machine learning unveils novel diagnostic signature and molecular features in chronic pancreatitis. Gut. 2026; PMID: 41991276.
- Zou WB, et al. Predictive Value of Machine Learning for Mortality Risk in Acute Pancreatitis: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2026; PMID: 41397146.
- Lu X, et al. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma. Gut. 2020; PMID: 31562239.
- Lichtenstein GR, et al. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2019; PMID: 30099108.
- Capurso G, et al. The Use of Complementary and Alternative Medicine is Frequent in Patients With Pancreatic Disorders. J Clin Gastroenterol. 2016; PMID: 27741165.
- Frulloni L, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009; PMID: 19940298.
- Papachristou GI, et al. Serum proteomic patterns as a predictor of severity in acute pancreatitis. Pancreatology. 2007; PMID: 17627096.